相关实验视频

Updated: Jun 8, 2025

Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood
11:17

Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood

Published on: October 12, 2012

13.7K

在患有脑静脉鼻血栓和前列血G20210A突变的患者中,埃诺沙巴林失败:病例报告

Adithya Polavarapu1, Anita Bhushan2, Walter Duarte-Celada3,4

  • 1Bhaskar Medical College (BMC), Hyderabad, Telangana, India.

The neurologist
|November 6, 2024
PubMed
概括

患有脑静脉鼻血栓症 (CVST) 和前热血素基因突变的患者可能会抵抗低分子量肝素 (LMWH). 对于这些人来说,未分离的肝素可能是一个更有效的治疗选择.

关键词:
抗凝固剂是一种抗凝固剂.脑血管疾病 脑血管疾病埃诺克萨帕林 (Enoxaparin) 是一种低分子量肝素是一种低分子量肝素.原血 G20210A 血栓友好症 血栓友好症鼻腔血栓形成的原因治疗失败的治疗失败.

更多相关视频

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease09:34

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Published on: April 4, 2018

33.6K
A Patient-Derived Xenograft Model for Venous Malformation06:51

A Patient-Derived Xenograft Model for Venous Malformation

Published on: June 15, 2020

5.3K

相关概念视频

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
624